APPLICATION OF A VALIDATED LONG-TERM RENAL TRANSPLANT GRAFT SURVIVAL PREDICTION MODEL TO EXPECTED BELATACEPT PHASE III TRIAL OUTCOMES

Transplantation Journal ◽

10.1097/00007890-201007272-00639 ◽

2010 ◽

Vol 90 ◽

pp. 341 ◽

Author(s):

M. A. Schnitzler ◽

D. Trivedi ◽

G. J. LʼItalien

Keyword(s):

Renal Transplant ◽

Prediction Model ◽

Graft Survival ◽

Phase Iii ◽

Survival Prediction ◽

Phase Iii Trial ◽

Download Full-text

LUX-Lung 8 phase III trial: Analysis of long-term response to second-line afatinib in patients with advanced squamous cell carcinoma (SCC) of the lung

Annals of Oncology ◽

10.1093/annonc/mdx091.022 ◽

2017 ◽

Vol 28 ◽

pp. ii37 ◽

Author(s):

J.C.-H. Yang ◽

G. Goss ◽

E. Felip ◽

S. Lu ◽

A. Ardizzoni ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Phase Iii ◽

Advanced Squamous Cell Carcinoma ◽

Second Line ◽

Phase Iii Trial ◽

Trial Analysis ◽

Download Full-text

Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2004.01.055 ◽

2004 ◽

Vol 59 (4) ◽

pp. 943-951 ◽

Author(s):

Steven E. Schild ◽

James A. Bonner ◽

Thomas G. Shanahan ◽

Burke J. Brooks ◽

Randolph S. Marks ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Long Term Results ◽

Small Cell Lung ◽

Phase Iii Trial

Download Full-text

Re: International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial

European Urology ◽

10.1016/j.eururo.2011.07.032 ◽

2011 ◽

Vol 60 (4) ◽

pp. 870-871

Author(s):

Damien Pouessel ◽

Stéphane Culine ◽

Pierre Mongiat-Artus

Keyword(s):

Bladder Cancer ◽

Phase Iii ◽

Long Term Results ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Phase Iii Trial ◽

Muscle Invasive

Download Full-text

Influence of renal function on long-term graft survival and patient survival in renal transplant recipients

Current Medical Research and Opinion ◽

10.1185/03007995.2013.855189 ◽

2013 ◽

Vol 30 (2) ◽

pp. 235-242 ◽

Author(s):

J. Smith-Palmer ◽

A. Kalsekar ◽

W. Valentine

Keyword(s):

Renal Function ◽

Renal Transplant ◽

Graft Survival ◽

Patient Survival ◽

Renal Transplant Recipients ◽

Transplant Recipients

Download Full-text

Faculty Opinions recommendation of Randomized Phase III Trial Evaluating Radiation Following Surgical Excision for Good-Risk Ductal Carcinoma In Situ: Long-Term Report From NRG Oncology/RTOG 9804.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.740667375.793588195 ◽

2021 ◽

Author(s):

Lorenzo Livi ◽

Isacco Desideri

Keyword(s):

Ductal Carcinoma In Situ ◽

Carcinoma In Situ ◽

Ductal Carcinoma ◽

Surgical Excision ◽

Phase Iii ◽

Phase Iii Trial ◽

Download Full-text

Phase III Trial of Early Intensified Chemotherapy (HDCT) with Autologous Bone Marrow Transplantation (ABMT) in First Line Treatment of Poor Risk Non-Seminomatous Germ Cell Tumours (NSGCT): Long Term Results of a Randomised Trial

Germ Cell Tumours III ◽

10.1016/b978-0-08-042198-8.50103-5 ◽

1994 ◽

pp. 429-430

Author(s):

J.F. Héron ◽

J.P. Droz ◽

J.L. Pico ◽

P. Biron ◽

P. Kerbrat ◽

...

Keyword(s):

Autologous Bone Marrow Transplantation ◽

Randomised Trial ◽

Autologous Bone Marrow ◽

Phase Iii ◽

Long Term Results ◽

Phase Iii Trial ◽

Autologous Bone ◽

Intensified Chemotherapy ◽

First Line Treatment

Download Full-text

Re: Karim Fizazi, Charles G. Drake, Tomasz M. Beer, et al. Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.032

European Urology ◽

10.1016/j.eururo.2020.09.049 ◽

2021 ◽

Vol 79 (1) ◽

pp. e10-e11

Author(s):

Ethan B. Ludmir ◽

Zachary R. McCaw ◽

Lee-Jen Wei

Keyword(s):

Prostate Cancer ◽

Final Analysis ◽

Phase Iii ◽

Castration Resistant Prostate Cancer ◽

Phase Iii Trial ◽

Castration Resistant ◽

Long Term Survivors

Download Full-text

Long-term treatment of Cushing’s disease with pasireotide: 5-year results from an open-label extension study of a Phase III trial

Endocrine ◽

10.1007/s12020-017-1316-3 ◽

2017 ◽

Vol 57 (1) ◽

pp. 156-165 ◽

Author(s):

S. Petersenn ◽

L. R. Salgado ◽

J. Schopohl ◽

L. Portocarrero-Ortiz ◽

G. Arnaldi ◽

...

Keyword(s):

Cushing’S Disease ◽

Term Treatment ◽

Phase Iii ◽

Cushing's Disease ◽

Extension Study ◽

Phase Iii Trial ◽

Long Term Treatment ◽

Open Label Extension

Download Full-text

Abstract GS3-06: Long-term follow-up of CALGB 40502/NCCTG N063H (Alliance): A randomized phase III trial of weekly paclitaxel (P) compared to weekly nanoparticle albumin bound nab-Paclitaxel (NP) or ixabepilone (Ix) +/- bevacizumab as first-line therapy for locally recurrent or metastatic breast cancer (MBC)

10.1158/1538-7445.sabcs17-gs3-06 ◽

2018 ◽

Author(s):

HS Rugo ◽

WT Barry ◽

A Moreno-Aspitia ◽

A Lyss ◽

L Huebner ◽

...

Keyword(s):

Metastatic Breast ◽

Phase Iii ◽

Phase Iii Trial ◽

First Line Therapy ◽

Line Therapy ◽

Long Term Follow Up ◽

Locally Recurrent

Download Full-text

Long-term Efficacy, Safety, and Immunogenicity of the Infliximab (IFX) Biosimilar, PF-06438179/GP1111, in Patients with Rheumatoid Arthritis After Switching from Reference IFX or Continuing Biosimilar Therapy: Week 54–78 Data From a Randomized, Double-Blind, Phase III Trial

BioDrugs ◽

10.1007/s40259-019-00403-z ◽

2020 ◽

Vol 34 (2) ◽

pp. 197-207 ◽

Author(s):

Stanley B. Cohen ◽

Sebastiao C. Radominski ◽

Hideto Kameda ◽

Alan J. Kivitz ◽

Michael Tee ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Phase Iii ◽

Double Blind ◽

Phase Iii Trial ◽

Download Full-text